An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases

Journal: Nature Communications

Published: 2019-11-08

DOI: 10.1038/s41467-019-13094-5

Affiliations: 5

Authors: 7

Go to article
Institutions Share
Department of Biomedical Engineering (BME), WFU, United States of America (USA) 0.50
Department of Microbiology and Immunology, WFU, United States of America (USA) 0.14
Section of Hematology and Oncology, WFU, United States of America (USA) 0.14
Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, United States of America (USA) 0.14
Department of Cancer Biology, WFU, United States of America (USA) 0.07

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER